Brokerage Mirae Asset Sharekhan has suggested buying five stocks from a long-term perspective. According to the analysts, ...
25m
Hosted on MSNEli Lilly Remains JPMorgan's Top Biopharma Pick For 2025, But Gilead And Bristol Myers Also Gain Praise — Is Retail On Board?JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) and Bristol Myers Squibb (BMY) as stocks with potential upside, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results